Invesco’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Invesco’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-132,977	Closed	-$887K	–	3918
2023 Q3	$887K	Buy	132,977 +70,196	+112%	+$583K	﹤0.01%	2923
2023 Q2	$569K	Buy	62,781 +17,532	+39%	+$155K	﹤0.01%	3170
2023 Q1	$329K	Buy	45,249 +12,637	+39%	+$93.7K	﹤0.01%	3467
2022 Q4	$238K	Sell	32,612 -149,838	-82%	-$1.11M	﹤0.01%	3616
2022 Q3	$1.41M	Sell	182,450 -2,640	-1%	-$22.4K	﹤0.01%	2786
2022 Q2	$1.26M	Buy	+185,090	New	+$1.42M	﹤0.01%	2897

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Invesco's PNT Position: Q4 2023 in Review

Invesco sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 132,977 shares — an estimated $887K sold.

Invesco first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $1.41M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Invesco reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Invesco sold 132,977 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $887K.
Invesco first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Invesco's POINT Biopharma Global Inc. Common Stock position peaked at $1.41M in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Invesco's 13F filing for Q4 2023, filed 13 Feb 2024.